Influence of physicians' risk perception on switching treatments between high- efficacy and non-high-efficacy disease‑modifying therapies in multiple sclerosis
Seifer, Gustavo Arun, Tarunya Capela, Carlos Laureys, Guy Jones, Eddie Dominguez-Castro, Patricia Sanchez-de la Rosa, Rainel Hiltl, Simone Iaffaldano, Pietro
Seifer, Gustavo
Arun, Tarunya
Capela, Carlos
Laureys, Guy
Jones, Eddie
Dominguez-Castro, Patricia
Sanchez-de la Rosa, Rainel
Hiltl, Simone
Iaffaldano, Pietro
Abstract
The decision of initiating treatment for multiple sclerosis (MS) with a high-efficacy DMT (HE DMT) or non-high-efficacy DMT (non-HE DMT) is influenced by several factors, including risk perception of patients and physicians.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2023-05-26
Type
Article
Collections
Citation
Mult Scler Relat Disord . 2023 Aug;76:104770